113
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Persistent HIV-1 replication maintains the tissue reservoir during therapy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lymphoid tissue is a key reservoir established by HIV-1 during acute infection. It is a site of viral production, storage of viral particles in immune complexes, and viral persistence. Whilst combinations of antiretroviral drugs usually suppress viral replication and reduce viral RNA to undetectable levels in blood, it is unclear whether treatment fully suppresses viral replication in lymphoid tissue reservoirs. Here we show that virus evolution and trafficking between tissue compartments continues in patients with undetectable levels of virus in their bloodstream. A spatial dynamic model of persistent viral replication and spread explains why the development of drug resistance is not a foregone conclusion under conditions where drug concentrations are insufficient to completely block virus replication. These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Dating of the human-ape splitting by a molecular clock of mitochondrial DNA.

          A new statistical method for estimating divergence dates of species from DNA sequence data by a molecular clock approach is developed. This method takes into account effectively the information contained in a set of DNA sequence data. The molecular clock of mitochondrial DNA (mtDNA) was calibrated by setting the date of divergence between primates and ungulates at the Cretaceous-Tertiary boundary (65 million years ago), when the extinction of dinosaurs occurred. A generalized least-squares method was applied in fitting a model to mtDNA sequence data, and the clock gave dates of 92.3 +/- 11.7, 13.3 +/- 1.5, 10.9 +/- 1.2, 3.7 +/- 0.6, and 2.7 +/- 0.6 million years ago (where the second of each pair of numbers is the standard deviation) for the separation of mouse, gibbon, orangutan, gorilla, and chimpanzee, respectively, from the line leading to humans. Although there is some uncertainty in the clock, this dating may pose a problem for the widely believed hypothesis that the pipedal creature Australopithecus afarensis, which lived some 3.7 million years ago at Laetoli in Tanzania and at Hadar in Ethiopia, was ancestral to man and evolved after the human-ape splitting. Another likelier possibility is that mtDNA was transferred through hybridization between a proto-human and a proto-chimpanzee after the former had developed bipedalism.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

            The hypothesis that quiescent CD4+ T lymphocytes carrying proviral DNA provide a reservoir for human immunodeficiency virus-type 1 (HIV-1) in patients on highly active antiretroviral therapy (HAART) was examined. In a study of 22 patients successfully treated with HAART for up to 30 months, replication-competent virus was routinely recovered from resting CD4+ T lymphocytes. The frequency of resting CD4+ T cells harboring latent HIV-1 was low, 0.2 to 16.4 per 10(6) cells, and, in cross-sectional analysis, did not decrease with increasing time on therapy. The recovered viruses generally did not show mutations associated with resistance to the relevant antiretroviral drugs. This reservoir of nonevolving latent virus in resting CD4+ T cells should be considered in deciding whether to terminate treatment in patients who respond to HAART.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

              The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy. Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral messenger RNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection. Uncertainty remains over what fraction of CD4+ T cells are infected and whether there are latent reservoirs for the virus. We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated provirus (<10(7) cells). The most prevalent form of HIV-1 DNA in resting and activated CD4+ T cells is a full-length, linear, unintegrated form that is not replication competent. The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+ T cells and macrophages.
                Bookmark

                Author and article information

                Contributors
                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                28 December 2015
                27 January 2016
                4 February 2016
                27 July 2016
                : 530
                : 7588
                : 51-56
                Affiliations
                Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60011, USA.
                Institute for Emerging Infections, Department of Zoology, University of Oxford, Oxford, OX1 3PS, UK.
                Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
                Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60011, USA.
                Centro de Investigação em Biodiversidade e Recursos Genéticos Universidade do Porto, Vairão, Portugal.
                Department of Medicine, University of California, San Diego, CA 92093, USA.
                Center for Infectious Disease Research, Korean National Institutes of Health, Osong, Korea.
                Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60011, USA.
                Department of Surgery, University of Minnesota, Minneapolis, MN, 55455 USA.
                Antiviral Pharmacology Laboratory, University of Nebraska Medical Center, College of Pharmacy, Omaha, NE 68198, USA.
                Division of Infectious Diseases, University of Minnesota, Minneapolis, MN 55455, USA.
                Department of Infectious Diseases, King's College London, Guy's Hospital, London, UK.
                Centre for Immunology, Infection and Evolution, University of Edinburgh, Edinburgh, UK.
                Department of Microbiology, University of Minnesota, Minneapolis, MN 55455, USA.
                Institute for Emerging Infections, Department of Zoology, University of Oxford, Oxford, OX1 3PS, UK.
                Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60011, USA.
                Author notes
                Correspondence and requests for materials should be addressed to Steven Wolinsky
                Article
                NIHMS746503
                10.1038/nature16933
                4865637
                26814962
                c287825a-d51a-4cb9-8083-4cceb180c4fc

                Reprints and permissions information is available at www.nature.com/reprints.

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article